EICHOR
● Completed
A 1-Year Study in Multiple Clinics Testing Rebamipide Eye Drops for Dry Eye Compared With a Placebo
Condition: Keratoconjunctivitis Sicca · Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
About this study
The purpose of this study is to determine the potential safety and effectiveness of rebamipide eye drops, an investigational eye drop being developed for the treatment of keratoconjunctivitis sicca (dry eye).
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (63)
| Alabama Research Center, LLC | Birmingham, Alabama, United States | — |
| Sun Valley Arthritis Center, Ltd. | Glendale, Arizona, United States | — |
| Pivotel Research Center | Peoria, Arizona, United States | — |
| Hope research Institute | Phoenix, Arizona, United States | — |
| Buena Vista Eye Care Center | Phoenix, Arizona, United States | — |
| Radiant Research | Scottsdale, Arizona, United States | — |
| Sall Eye Research Center | Artesia, California, United States | — |
| Radiant Research - Irvine | Irvine, California, United States | — |
| Scripps Clinic Medical Group, Inc. | La Jolla, California, United States | — |
| American Eye Institute | Los Angeles, California, United States | — |
| Eye Clinic of San Diego | San Diego, California, United States | — |
| Healthcare Partners Medical Group | Torrance, California, United States | — |
+ 51 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT00201981